Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Valeant Canada LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10907
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical products manufacturing company. The company offers products such as aczone, airomir, aldara, benzaclin topical gel, benzamycin, biacna topical gel, C.E.S. tablets, carbolith, cardizem cd, cuprimine, dermatop cream, dermatop ointment, edecrin, efudex cream, elidel, etibi, glumetza, glycon, lodalis, loperacap, loprox cream, loprox lotion, mestinon tab, mestinon sr. It provides minitran, nidagel, nitoman, noritate, oxybutin, penlac, qvar, retin-a, retin-a micro, rofact, sodium edecrin, sulfacet r, theolair, tiazac, tiazac xc, topicort cream, topicort gel, topicort ointment, tryptan, ultravate, virazole, viroptic, vitamin a acid and vyloma, among others. Valeant Canada markets its products to pharmacies, healthcare practices and hospitals. The company operates manufacturing facilities in Manitoba, Ontario and Quebec. Valeant Canada is headquartered in Laval, Quebec, Canada.

Valeant Canada LP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeant Canada LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Valeant Canada LP, Medical Devices Deals, 2012 to YTD 2018 9
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Valeant Canada LP, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Valeant Canada Acquires Canadian Rights from Sanofi-aventis for Altace and Altace HCT 11
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 12
Partnerships 13
Orexigen Therapeutics Enters Into Distribution Agreement With Valeant For Contrave 13
Licensing Agreements 14
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 14
Acquisition 15
Valeant Canada Acquires CROMA Pharma Canada 15
Valeant Canada LP – Key Competitors 16
Valeant Canada LP – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Valeant Canada LP, Pharmaceuticals & Healthcare, Key Facts 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeant Canada LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeant Canada LP, Deals By Therapy Area, 2012 to YTD 2018 8
Valeant Canada LP, Medical Devices Deals, 2012 to YTD 2018 9
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Valeant Canada Acquires Canadian Rights from Sanofi-aventis for Altace and Altace HCT 11
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 12
Orexigen Therapeutics Enters Into Distribution Agreement With Valeant For Contrave 13
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 14
Valeant Canada Acquires CROMA Pharma Canada 15
Valeant Canada LP, Key Competitors 16
Valeant Canada LP, Other Locations 16

List of Figures
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Valeant Canada LP, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hycrete Inc:企業の戦略的SWOT分析
    Hycrete Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pregis LLC:企業の戦略・SWOT・財務分析
    Pregis LLC - Strategy, SWOT and Corporate Finance Report Summary Pregis LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, i …
  • Platte River Power Authority:企業の発電所・SWOT分析2018
    Platte River Power Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Celgene Corp (CELG)-製薬・医療分野:企業M&A・提携分析
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Bharat Heavy Electricals Ltd (BHEL)-エネルギー分野:企業M&A・提携分析
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …
  • Theranostics Health Inc-医療機器分野:企業M&A・提携分析
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析
    SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mitsubishi Paper Mills Ltd (38640):企業の財務・戦略的SWOT分析
    Mitsubishi Paper Mills Ltd (38640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Edmond De Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務分析
    Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mindray Medical International Ltd-医療機器分野:企業M&A・提携分析
    Summary Mindray Medical International Ltd (Mindray) is a medical device company. Its major products include multi-parameter patient monitors, telemetry monitoring system, defibrillator, anesthesia machine, surgical lights, ceiling supply units, veterinary monitoring systems, hematology analyzer and …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Zecotek Photonics Inc (ZMS)-医療機器分野:企業M&A・提携分析
    Summary Zecotek Photonics Inc. (Zecotek) is a photonics technology company. It develops and sells scintillation crystals, photo detectors, positron emission tomography scanner technologies, 3D auto-stereoscopic displays, fiber lasers and waveguide micro lasers. Zecotek’s product portfolio includes L …
  • CharlestonPharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary CharlestonPharma LLC (CharlestonPharma) is a drug development company that develops anti-nucleolin antibodies for the treatment of cancer. The company uses in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that targets nucleolin located i …
  • Apache Corporation:企業の戦略・SWOT・財務情報
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • 4SC AG (VSC):企業の財務・戦略的SWOT分析
    4SC AG (VSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Genedrive Plc (GDR):企業の製品パイプライン分析
    Summary Genedrive Plc (Genedrive), formerly Epistem Holdings plc, develops and markets point of need molecular diagnostics platform for identifying infectious diseases and pathogens and providing other indications. The Genedrive HCVID test is the company’s CE-IVD certified molecular diagnostics plat …
  • Lincoln Educational Services Corp (LINC):企業の財務・戦略的SWOT分析
    Summary Lincoln Educational Services Corp (Lincoln) is an educational service provider that operates schools, colleges and technical institutes. The organization offers student services including admissions, financial aid, academics, and career services. It provides educational programs in the areas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆